source
- General Catalyst outlines tech collaborations with Summa Health after hospital acquisitionGeneral Catalyst, a venture capital firm, is now describing how it plans to integrate technology with Summa Health following its purchase of the hospital network. The firm says the focus will be o…
- FDA approves Ultragenyx's gene therapy for Sanfilippo syndrome type AThe FDA granted full approval to a rare disease gene therapy from Ultragenyx on Thursday, giving the company a much-needed boost in an otherwise difficult year. The therapy, called UX111, will be b…Endpoints · 1mo ago↗ source
- Two more biotechs, Marea and North Immunology, do reverse mergers